ImClone Systems NewsNews on ImClone Systems continually updated from thousands of sources around the net.A New Suitor for ImClone Icahn Says So- September 12, 2008 This news has IMCL nearly 7.5% higher in afternoon trading, with a price of $68.26. Since BMY's $60 offer, the stock has traded above $60, suggesting that investors expect more for IMCL.http://www.topix.net/com/imcl/2008/09/a-new-suitor-for-imclone-icahn-says-so?fromrss=1 Big Pharma set for costly shopping spree- September 11, 2008 LONDON : The existing drugs aren't working, so big pharmaceutical companies are set to step up the hunt for assets to buy in promising fields like biotechnology, as well as non-prescription areas of healthcare.http://www.topix.net/com/imcl/2008/09/big-pharma-set-for-costly-shopping-spree?fromrss=1 ImClone Systems Incorporated and Bristol-Myers Squibb Company Erbitux ...- September 11, 2008 ImClone Systems Inc. and Bristol-Myers Squibb Co. said a Phase 3 trial of Erbitux showed that adding the blockbuster cancer drug to platinum- based chemotherapy improved survival rates in patients with head and ...http://www.topix.net/com/imcl/2008/09/imclone-systems-incorporated-and-bristol-myers-squib... Business highlights: Lehman tries to soothe Wall Street- September 11, 2008 NEW YORK - Lehman Brothers, in a desperate bid to survive, announced plans Wednesday to sell a majority stake in its prized investment management business and said a sale of the entire company is possible.http://www.topix.net/com/imcl/2008/09/business-highlights-lehman-tries-to-soothe-wall-stre... Movers: Lehman, FedEx, ImClone Systems, Kraft- September 11, 2008 Lehman Brothers posts preliminary $5.92 third quarter loss per share, on net revenue of negative $2.9 billion.http://www.topix.net/com/imcl/2008/09/movers-lehman-fedex-imclone-systems-kraft-2?fromrss=... East Bay drug developers scramble for money- September 8, 2008 Small and mid-sized public biotech and drug companies in the East Bay have turned in decidedly mixed results so far in 2008.http://www.topix.net/com/imcl/2008/09/east-bay-drug-developers-scramble-for-money?fromrss=... Imclone, Bristol Deal Still Stuck In A Rut- September 6, 2008 Seems like an odd way to buy a company. The prospective buyer makes an offer. The seller rejects it as too low.http://www.topix.net/com/imcl/2008/09/imclone-bristol-deal-still-stuck-in-a-rut?fromrss=1 ImClone Submits Supplemental Biologics License Application for...- September 3, 2008 ImClone Systems Incorporated today announced that it has submitted an application to the U.S. Food and Drug Administration to broaden the use of ERBITUX to include first-line treatment of patients with ...http://www.topix.net/com/imcl/2008/09/imclone-submits-supplemental-biologics-license-appli... Biotech Drops Back to Earth in August, Burrill Finds- September 2, 2008 Sep 2, 2008 - While the general markets managed to end August in positive territory as oil continued a sharp slide, biotech came back to earth after its stellar performance in July closing in negative ...http://www.topix.net/com/imcl/2008/09/biotech-drops-back-to-earth-in-august-burrill-finds?... Zacks Analyst Interview Highlights: Genentech, ImClone Systems, Bristol-Myers Squibb and Celgene- September 2, 2008 Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: http:at.zacks.comid=2678 . Are you expecting M&A activity to continue in biotech If so, for how ...http://www.topix.net/com/imcl/2008/09/zacks-analyst-interview-highlights-genentech-imclone... |